New weight-loss drug tested in chinese adults with diabetes
NCT ID NCT06988553
First seen Nov 01, 2025 · Last updated May 24, 2026 · Updated 29 times
Summary
This early-stage study tested a new drug called AZD5004 in 45 Chinese adults who were overweight or obese, some with type 2 diabetes. The main goal was to check if the drug is safe and how the body processes it, compared to a placebo. Researchers measured side effects and drug levels in the blood over time.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
General Hospital of Tianjin Medical University
Tianjin, China
-
Jinan Central Hospital
Jinan, China
-
Shanghai Pudong New District People's Hospital
Shanghai, China
-
The Fourth Affiliated Hospital of Harbin Medical University
Ha’erbin, China
-
The Second People's Hospital of Hefei
Hefei, China
-
West China Hospital, Sichuan University
Chengdu, Sichuan, 610041, China
Conditions
Explore the condition pages connected to this study.